Yes Aim agree and sorry Silverphil I missed your second post about the Medicare Accreditation (trying to read posts from mobile very frustrating!!).
Yesterday afternoon I replied back to Tom with this, haven't got an naswer as yet:
" Tom, Is there any reason why GTG does not see it fit to publish an anouncement about the fact that Rosetta's miRview tests, which GTG will be marketing in the Pacific, has recently gained Medicare Accreditation in the U.S? I realise that this accreditation is only currently for the U.S market but surely this would be seen as a positive reinforcement of GTG's direction and the products/services it offers.
"
GTG Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
